Logotipo del repositorio
Logotipo del repositorio
 

Reporte de 4 casos COVID-19 hospitalizados en unidad de cuidados intensivos en una institución hospitalaria en Barranquilla, Colombia

Vista sencilla de ítem
dc.contributor.authorIglesias Pertuz, Shirley
dc.contributor.authorAroca-Martinez, Gustavo
dc.contributor.authorVelez-Verbel, María
dc.contributor.authorCadena Osorio, Andrés
dc.contributor.authorCorrea-Monterrosa, Mileidys
dc.contributor.authorCadena-Bonfanti, Andrés
dc.contributor.authorLemus Castro, Jorge
dc.contributor.authorBrochado, Leonardo
dc.contributor.authorArmesto, Wilfredo
dc.contributor.authorCamargo Vasquez, Tomas
dc.contributor.authorMartínez Bula, Eduardo
dc.contributor.authorAvendaño Echavez, Lil Geraldine
dc.contributor.authorHernández-Agudelo, Sandra
dc.contributor.authorTurizo Turizo, Erika
dc.contributor.authorPeña Vargas, William
dc.contributor.authorRiascos, William
dc.contributor.authorSierra, Angélica
dc.contributor.authorVarón Suarez, Favio
dc.contributor.authorGómez Giraldo, Luisa
dc.contributor.authorGonzalez-Torres, Henry
dc.contributor.authorNavarro Quiroz, Elkin
dc.contributor.authorVásquez Obeso, Esteban
dc.contributor.authorÁngel Depine, Santos
dc.contributor.authorOspino Herrera, Daniel
dc.date.accessioned2020-04-14T23:50:55Z
dc.date.available2020-04-14T23:50:55Z
dc.date.issued2020
dc.description.abstractObjetivo: Presentar una serie de casos de COVID-19 con requerimiento de ingreso a Unidad de Cuidados Intensivos. Métodos: La información fue tomada de las historias clínicas, y su evaluación y diagnóstico fue realizado mediante estudios paraclínicos en sangre, orina, PCR e imágenes diagnósticas en 4 pacientes con diferentes comorbilidades y nexo epidemiológico presente para desarrollo de la enfermedad. El caso 1 desarrolló falla orgánica múltiple, incluyendo injuria renal aguda con una estancia en UCI de 4 dias antes de su fallecimiento, mientras los casos 2, 3 y 4 tuvieron una evolución favorable y fueron dados de alta de UCI. Los cuatro casos fueron manejados con cloroquina 300 mg via oral cada 12 horas y azitromicina 1 gr via oral cada 24 horas durante 5 dias sin complicaciones ni toxicidad asociada. Conclusiones: Se requieren estudios multicéntricos rápidos que orienten científicamente hacia un mejor abordaje diagnóstico y manejo, en el contexto de una enfermedad con un comportamiento clínico-epidemiologico que debe estudiarse en profundidad y que probablemente cobrará muchas vidas, ademas, debido a la ausencia de pruebas diagnósticas rápidas, la utilización de una clasificación basada en la severidad de lesiones radiológicas llamada CO-RADS (Covid-19 Imaging Reporting and Data System), podría ser de gran importancia para instalar de manera temprana los tratamientos farmacológicos disponibles y la asistencia respiratoria mecánica precoz.spa
dc.description.abstractObjective: To present a COVID-19 case series with clinical admission criteria to Intensive Care Unit. Methods: Patients information was obtained from medical records, and daily clinical evaluation whereas diagnosis was carried out through paraclinical studies in blood, urine, PCR and diagnostic images in 4 patients with different comorbidities and epidemiological link for the development of COVID19. The case 1 developed multiple organ failure, including acute kidney injury with an ICU stay of 4 days before his death, while cases 2, 3 and 4 had a favorable evolution and were discharged from the ICU. All four cases were managed with chloroquine 300 mg orally every 12 hours and azithromycin orally every 24 hours for 5 days without complications or associated toxicity. Conclusions: rapid multicenter studies are required to scientifically guide a better diagnostic and management approach, in the context of a disease with a clinical-epidemiological behavior that must be studied in depth and will probably take many lives. In addition, due to the absence of sufficiently rapid tests, the use of a classification based on the severity of radiological lesions called CO-RADS (Covid-19 Imaging Reporting and Data System), could be of great importance to install avaspa
dc.format.mimetypepdfspa
dc.identifier.doihttps://doi.org/10.22265/acnef.7.Supl%202.420
dc.identifier.issn25005006spa
dc.identifier.urihttps://hdl.handle.net/20.500.12442/5107
dc.identifier.urlhttps://revistanefrologia.org/index.php/rcn/article/view/420
dc.language.isospaspa
dc.publisherAsociación Colombiana de Nefrología e Hipertensión Arterialspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceRevista Colombiana de Nefrología
dc.sourceVol. 7, No. supl 2 (20) (2020)
dc.subjectCoronavirusspa
dc.subjectCOVID-19spa
dc.subjectSars-CoV-2spa
dc.subjectInjuria renal agudaspa
dc.subjectFalla multisistémicaspa
dc.subjectCloroquinaspa
dc.subjectAzitromicinaspa
dc.subjectUCIspa
dc.subjectAcute kidney injuryen
dc.subjectMulti-system failure,en
dc.subjectChloroquineen
dc.subjectAzithromycinen
dc.subjectICUen
dc.subjectCOVID-19en
dc.subjectSars-CoV-2en
dc.subjectCoronavirusen
dc.titleReporte de 4 casos COVID-19 hospitalizados en unidad de cuidados intensivos en una institución hospitalaria en Barranquilla, Colombiaspa
dc.title.translatedCase-Serie of 4 COVID-19 patients hospitalized in an intensive care unit in a hospital institution in Barranquilla, Colombiaen
dc.typearticlespa
dc.type.driverarticlespa
dcterms.referencesWorld Health Organization. Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-atthe-media-briefing-on-2019-ncov-on-11-february-2020. 2020.en
dcterms.referencesZaki AM, Van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–20.en
dcterms.referencesWilde AH de, Snijder EJ, Kikkert M, Van MJ. Host Factors in Coronavirus Replication. Curr Top Microbiol Immunol [Internet]. 2017;37:35. Available from: http://books.google.com/books?id=_DDwCqx6wpcC&printsec=frontcover&dq =unwritten+rules+of+phd+research&hl=&cd=1&source=gbs_api%255Cnpap ers2://publication/uuid/48967E01-55F9-4397-B941- 310D9C5405FA%255Cnhttp://medcontent.metapress.com/index/A65RM03P 4874243N.pdf%255en
dcterms.referencesMüller MA, Corman VM, Jores J, Meyer B, Younan M, Liljander A, et al. Mers coronavirus neutralizing antibodies in camels, eastern Africa, 1983–1997. Emerg Infect Dis. 2014;20(12):2093–5.en
dcterms.referencesOrganización Mundial de la Salud. Nuevo coronavirus - China. 2020.spa
dcterms.referencesVardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020;18(March):20.en
dcterms.referencesHan R, Huang L, Jiang H, Dong J, Peng H, Zhang D. Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia. Am J Roentgenol. 2020;(1):1–6.en
dcterms.referencesWang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc. 2020;323(11):1061–9.en
dcterms.referencesGrasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. Jama [Internet]. 2020;1–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32250385en
dcterms.referencesGrasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy. JAMA - J Am Med Assoc. 2020;en
dcterms.referencesWu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - J Am Med Assoc. 2020;2019:3–6.en
dcterms.referencesOnder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. Jama [Internet]. 2020;2019:2019–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32203977en
dcterms.referencesSalud instituto nacional de. Coronavirus (COVID - 2019) en Colombia. 2020.spa
dcterms.referencesSmithuis F, Smithuis R. 32 cases of suspected COVID-19 Imaging findings and follow up. Radiology Assistant. 2020. p. https://radiologyassistant.nl/chest/covid-19-ct-fi.en
dcterms.referencesWorld Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report – 82. 2020.en
dcterms.referencesBhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. N Engl J Med. 2020 Mar;NEJMoa2004500en
dcterms.referencesLiu Y, Yan L-M, Wan L, Xiang T-X, Le A, Liu J-M, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis [Internet]. 2020;2019(20):2019–20. Available from: https://doi.org/10.1016/S1473- 3099(20)30232-2en
dcterms.referencesZhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020;395(10229):1054–62. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30566-3en
dcterms.referencesLi Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med. 2020;1199–207.en
dcterms.referencesHuang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.en
dcterms.referencesZhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020;395(10229):1054–62. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30566-3en
dcterms.referencesMurthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients with COVID-19. JAMA - J Am Med Assoc. 2020;1–2.en
dcterms.referencesWang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, et al. Comorbidities and multiorgan injuries in the treatment of COVID-19. Lancet [Internet]. 2020;395(10228):e52. Available from: http://dx.doi.org/10.1016/S0140- 6736(20)30558-4en
dcterms.referencesPanitchote A, Mehkri O, Hasting A, Hanane T, Demirjian S, Torbic H, et al. Factors associated with acute kidney injury in acute respiratory distress syndrome. Ann Intensive Care [Internet]. 2019;9(1). Available from: https://doi.org/10.1186/s13613-019-0552-5en
dcterms.referencesCheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 Mar;(March).en
dcterms.referencesVolunteers A-2019-nCoV, Li Z, Wu M, Guo J, Yao J, Liao X, et al. Caution on Kidney Dysfunctions of 2019-nCoV Patients. medRxiv. 2020;2020.02.08.20021212.en
dcterms.referencesBai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020;200823.en
dcterms.referencesSimpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging. 2020;2(2):e200152.en
dcterms.referencesColson P, Rolain J-M, Lagier J-C, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents [Internet]. 2020;105932. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32145363en
dcterms.referencesYao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Main point : Hydroxychloroquine was found to be more potent than chloroquine at inhibiting SARS-CoV-2 in vit. Clin Infect Dis. 2020;2:1–25.en
dcterms.referencesGautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents [Internet]. 2020;105949. Available from: https://doi.org/10.1016/j.ijantimicag.2020.105949en
dcterms.referencesChan JFW, Yanfeng Yao A, Yeung M-L, Deng W, Bao L, Lilong, et al. Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a non-human primate model of common marmoset. J Infect Dis. 2020;212(12).en
oaire.versioninfo:eu-repo/semantics/publishedVersionspa

Archivos

Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Reporte de 4casos COVID-19.pdf
Tamaño:
1.02 MB
Formato:
Adobe Portable Document Format
Descripción:
PDF
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
381 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos

Universidad Simón Bolívar: Todos los derechos reservados / Sistema de biblioteca